Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 54, Issue 8, Pages 3512-3515Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01646-09
Keywords
-
Categories
Funding
- French Ministry of Health via the Institut de Veille Sanitaire
Ask authors/readers for more resources
A nationwide study aimed to identify the extended-spectrum beta-lactamases (ESBLs), metallo-beta-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in a French collection of 140 clinical Pseudomonas aeruginosa isolates highly resistant to ceftazidime. Six ESBLs (PER-1, n = 3; SHV-2a, n = 2; VEB-1a, n = 1), four MBLs (VIM-2, n = 3; IMP-18, n = 1), and five ES-OXAs (OXA-19, n = 4; OXA-28, n = 1) were identified in 13 isolates (9.3% of the collection). The prevalence of these enzymes is still low in French clinical P. aeruginosa isolates but deserves to be closely monitored.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available